Vyvanse (lisdexamfetamine)
ADHD
CommercialApproved
Key Facts
About Takeda Pharmaceutical
Founded in 1781, Takeda is a leading global biopharmaceutical company headquartered in Tokyo, Japan, with operations in over 80 countries. The company transformed through strategic acquisitions including Shire in 2019, building a diversified portfolio in oncology, rare diseases, neuroscience, and gastroenterology. Takeda focuses on developing breakthrough therapies while maintaining a strong commercial presence with blockbuster drugs generating billions in annual revenue.
View full company profileTherapeutic Areas
Other ADHD Drugs
| Drug | Company | Phase |
|---|---|---|
| Centanafadine | Otsuka Holdings | Phase 3 |
| TCM-based formulation | Regencell Bioscience | Preclinical |
| Methylphenidate ER | Lupin Limited | Approved |
| Adderall XR® | Supernus Pharmaceuticals | Approved/Commercial |
| Intuniv® | Supernus Pharmaceuticals | Approved/Commercial |
| Mydayis® | Supernus Pharmaceuticals | Approved/Commercial |